20170823: AXL+GAS6 IgM ICC Zika-GBS patients

Objectives

To test  Zika-GBS patients for IgM  positivity towards human AXL+GAS6 complex in HEK 293 transfected cells.

Patients

codio laboratorioCODGENDERAGEDX-COD
1ZN001A144GUILLAIN BARRÉ SYNDROME
27ZN002A053GUILLAIN BARRÉ SYNDROME
5ZN004A047GUILLAIN BARRÉ SYNDROME
57ZN006A038GUILLAIN BARRÉ SYNDROME
21ZN007A043GUILLAIN BARRÉ SYNDROME
18ZN008A047GUILLAIN BARRÉ SYNDROME
15ZN010A027GUILLAIN BARRÉ SYNDROME
4ZN011A142GUILLAIN BARRÉ SYNDROME
33ZN012A122Encephalitis
9ZN013A149GUILLAIN BARRÉ SYNDROME
2ZN014A070GUILLAIN BARRÉ SYNDROME
44ZN015A034GUILLAIN BARRÉ SYNDROME / BICKERSTAFF
40ZN016A041GUILLAIN BARRÉ SYNDROME
46ZN017A158GUILLAIN BARRÉ SYNDROME
13ZN018A138GUILLAIN BARRÉ SYNDROME
19ZN019A110GUILLAIN BARRÉ SYNDROME
30ZN020A126Peripheral facial palsy
10ZN022A169GUILLAIN BARRÉ SYNDROME
25ZN023A033Encephalitis
48ZN025A18Transverse myelitis
47ZN026A162GUILLAIN BARRÉ SYNDROME
12ZN027A022Transverse myelitis
51ZN039A018GUILLAIN BARRÉ SYNDROME
36ZN040A041Transverse myelitis
17ZN041A145GUILLAIN BARRÉ SYNDROME
41ZN043A142GUILLAIN BARRÉ SYNDROME
28ZN044A025GUILLAIN BARRÉ SYNDROME
59ZN045A123Peripheral facial palsy
34ZN046A149GUILLAIN BARRÉ SYNDROME
20ZN047A125Myeloradiculopathy
45ZN048A027GUILLAIN BARRÉ SYNDROME
22ZN052A027GUILLAIN BARRÉ SYNDROME
58ZN055A154GUILLAIN BARRÉ SYNDROME
23ZN056A023Transverse myelitis
43ZN057A042GUILLAIN BARRÉ SYNDROME
32ZN058A140Peripheral facial palsy
54ZN061A035GUILLAIN BARRÉ SYNDROME

Las muestras LAB ID 6,11, 26, 56 y 55 no se han podido analizar por falta de suero.

 AXL+GAS6  ICC

  • Human AXL+GAS6 transfected HEKs 293 grown in coverslips (plates). Fixed with PFA 4%, permeabilized  and blocked with 5% goat serum in  PBS.
  • PBS
  • Blocking solution: 5% goat serum in  PBS
  • Patient’s sera diluted 1/40 (IgM) with 5% goat serum in  PBS.
  • Primary Ab: Mouse-anti-AXL (MAB154 R&D Systems) 1/500
  • Secondary Abs: GAM 488 (1/500)+ GAH 594 IgM (1/500)
  • Vectashield mounting medium

Results

All samples are negative.

Print Friendly, PDF & Email

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.